Olivier Bron, who serves as CEO of Bloomingdale's, disposed of 7,228 shares of Macy's Inc. common stock (ticker: M) on April 6, 2026, generating approximately $129,555 in proceeds. The shares were sold at a weighted average price of $17.9241, with sale prices reported between $17.86 and $17.97. The stock is trading at $18.11, reflecting a 75% gain over the past 12 months while having declined 17% year-to-date.
The company said the sale was executed to satisfy tax withholding obligations that arose upon the vesting of restricted shares. Macy's characterized the transaction as non-discretionary rather than a voluntary sale.
Separately, on April 3, Bron exercised options that resulted in the acquisition of 13,146 shares of Macy's common stock through the conversion of Restricted Stock Units.
Quarterly results and analyst reaction
Macy's reported a fourth-quarter earnings per share of $1.67, beating expectations of $1.57. The retailer also posted a 1.8% increase in same-store sales, defying forecasts that had expected a 0.9% decline. Despite those upside surprises, analysts remain divided in their outlooks for Macy's.
UBS maintained its Sell rating on Macy's, citing concerns about market share losses and projecting continued earnings pressure. TD Cowen adjusted its price target to $20 from $21 while keeping a Hold rating, attributing the change to margin concerns. Telsey lowered its price target to $20 from $25, pointing to macroeconomic uncertainty but noting positive comparable sales across Macy's nameplates.
Evercore ISI trimmed its price target to $19 from $21, flagging valuation concerns even as Macy's delivered a better-than-expected EBIT margin of 7.7%. Jefferies reiterated a Buy rating with a $22 price target, emphasizing the company's earnings beat while noting that Macy's fiscal 2026 guidance was below Wall Street estimates. These developments reflect a mix of optimism and caution among analysts regarding Macy's future performance.
Context and market impact
The insider transaction was a routine, tax-related sale following RSU vesting and was not characterized as discretionary. The company-level results and the range of analyst stances together sketch a picture of stronger near-term operating performance counterbalanced by concerns over margins, valuation, and guidance.